ChinaFile Recommends
07.18.13China Bars GlaxoSmithKline Executive From Leaving During a Bribery Inquiry
New York Times
The effort to restrict Steve Nechelput’s travel came as the government ramped up an unusually bold anti-corruption campaign against GlaxoSmithKline, which is one of the world’s biggest drug makers.